Systemic AL-amyloidosis

被引：1
|
作者：
Boeckle, Barbara C. [1 ]
Sepp, Norbert T. [1 ,2 ]
机构：
[1] Med Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria
[2] Barbara Bommer Fdn Clin Immunodermatol, Innsbruck, Austria
来源：
LANCET | 2014年 / 384卷 / 9939期
关键词：
D O I：
10.1016/S0140-6736(13)60859-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：257 / 257
页数：1
相关论文
共 50 条
  • [31] Clues to diagnosis of AL-amyloidosis: two cases
    Akar, H.
    Cengiz, O.
    Yuceturk, H.
    Akdam, H.
    Meteoglu, I.
    Yavasoglu, Y.
    Kacar, D. F.
    Kadikoylu, G.
    Yenicerioglu, Y.
    Bolaman, Z.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 177 - 178
  • [32] What is the role of giant cells in AL-amyloidosis?
    Olsen, KE
    Sletten, K
    Sandgren, O
    Olsson, H
    Myrvold, K
    Westermark, P
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 1999, 6 (02): : 89 - 97
  • [33] Apoptosis in cardiomyocytes in AA- and AL-amyloidosis
    Rybakova, M.
    Kuznetsova, I.
    Tikhonova, J.
    VIRCHOWS ARCHIV, 2014, 465 : S130 - S130
  • [34] Therapy and prophylaxis of bleeding symptoms in a patient with acquired factor X-deficiency due to systemic amyloidosis (AL-Amyloidosis)
    Klamroth, R
    Heinrichs, C
    32ND HEMOPHILIA SYMPOSIUM, 2003, : 168 - 170
  • [35] Outcome of clinical experience of introducing a patient with secondary systemic AL-amyloidosis associated with multiple myeloma
    Novosad, Olga
    Rudiuk, Tymur
    Shevchuk, Lesya
    Kundina, Viktoriia
    Schmidt, Anna
    CARCINOGENESIS, 2023, 44 (01) : 46 - 53
  • [36] Epidemiological data on AL-amyloidosis from the amyloidosis registry of the comprehensive amyloidosis network Zurich
    Schwotzer, R.
    Flammer, A.
    Averaimo, M.
    Biedermann, L.
    Brouwers, S.
    Ehl, N.
    Fehr, T.
    Heimgartner, R.
    Hitz, F.
    Jung, H. H.
    Kaelin, J.
    Laptseva, N.
    Manz, M. M.
    Mihaylova, V.
    Muellhaupt, B.
    Ruschitzka, F.
    Seeger, H.
    Vetter, F.
    Zweier, M.
    Gerber, B.
    SWISS MEDICAL WEEKLY, 2021, 151 : 33 - 33
  • [37] Clinicopathologic and Proteomic Characteristics of Intratubular Cytoplasmic AL-Amyloidosis
    Javaugue, Vincent
    Rocha, Alejandro Best
    Said, Samar M.
    Santoriello, Dominick
    Hou, Jean
    Dasari, Surendra
    Theis, Jason D.
    Vrana, Julie A.
    Batal, Ibrahim
    Larsen, Christopher P.
    Markowitz, Glen S.
    D'Agati, Vivette D.
    Mcphail, Ellen D.
    Leung, Nelson
    Nasr, Samih H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 377 - 378
  • [38] Calreticulin, AL-amyloidosis and high-dose melphalan
    Zhou, P.
    Teruya-Feldstein, J.
    Lu, P.
    Clark, B.
    Fleisher, M.
    Olshen, A.
    Comenzo, R. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 201 - 201
  • [39] The role of high-dose therapy in AL-amyloidosis
    Comenzo, R. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 60 - 61
  • [40] Treatment of AL-amyloidosis with dexamethasone plus alpha interferon
    Dhodapkar, MV
    Jagannath, S
    Vesole, D
    Munshi, N
    Naucke, S
    Tricot, G
    Barlogie, B
    LEUKEMIA & LYMPHOMA, 1997, 27 (3-4) : 351 - 356
12345